Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04689880 · ClinicalTrials.gov registry record
XLIF Decade Plate System Study
A clinical trial, sponsored by NuVasive.
- Completed
- Registry status
- 75
- Enrollment target
NCT04689880: Completed study, sponsored by NuVasive.
NCT04689880 is a clinical trial that has completed, run by NuVasive. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04689880 has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety and performance of the NuVasive XLIF Decade Plate System as measured by patient-reported outcomes (PROs), radiographic outcomes, and reported complications.
Primary Outcome
Rate of device-related complications (i.e., safety) attributable to the use of the Decade Plate System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-04-12 |
| Est. Completion | 2023-04-01 |
What the finished NCT04689880 record still lists
NCT04689880 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04689880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04689880 about?
NCT04689880 is a clinical study titled "XLIF Decade Plate System Study". The primary objective of this study is to evaluate the safety and performance of the NuVasive XLIF Decade Plate System as measured by patient-reported outcomes (PROs), radiographic outcomes, and reported complications.
What is the current status of trial NCT04689880?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2021-04-12. Estimated completion is 2023-04-01.
Who is sponsoring clinical trial NCT04689880?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI